SM
PTLA

Sabby Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Sabby Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,560
Closed -$14M – 280
2017
Q1 		$14M Buy
3,560
+1,757
+97% +$56K 0.75% 23
2016
Q4 		$4.05M Buy
1,803
+1,503
+501% +$29.4K 0.24% 62
2016
Q3 		$681K Buy
+300
New +$7.04K 0.03% 207
2016
Q2 		– Sell
-3,221
Closed -$6.57M – 358
2016
Q1 		$6.57M Buy
3,221
+3,104
+2,653% +$98.5K 0.33% 34
2015
Q4 		$602K Buy
+117
New +$5.67K 0.03% 224

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Sabby Management's PTLA Position: Q1 2016 in Review

Sabby Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2016, closing a stake of 3,900 shares — an estimated $124K sold.

Sabby Management first reported a position in PTLA in Q3 2015 and held it in 2 quarters. The position peaked at $477K in Q3 2015. 167 funds tracked by Wall St. Rank hold PTLA as of Q1 2016.

  • Sabby Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Sabby Management sold 3,900 Portola Pharmaceuticals, Inc. shares in Q1 2016, an estimated $124K.
  • Sabby Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2015 and held it in 2 quarters.
  • Sabby Management's Portola Pharmaceuticals, Inc. position peaked at $477K in Q3 2015.
  • 167 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2016.

Based on Sabby Management's 13F filing for Q1 2016, filed 13 May 2016.